Logo

heart disease

Cardio Diagnostics Enters Private Financing Agreement for up to $11.2M

The firm intends to use the proceeds to accelerate the adoption of its PrecisionCHD and Epi+Gen CHD tests and to launch additional tests.

Numares Health Gets €40M Financing from European Investment Bank, Existing Investors

Numares will use €20 million from the EIB for research and development and the complementary €20 million from other investors to commercialize its technology.

Cardio Diagnostics Prepares for New Test Launches Following IPO
Premium

The firm uses epigenetic and genetic information, along with machine learning to determine a patient's risk of cardiovascular disease.

Cardio Diagnostics to Go Public via Merger With SPAC

The combined firm is expected to have an approximate post-transaction equity market capitalization of $175 million.

Industry Testing Alliance Seeks to Broaden Use of Cardiogenomic NGS Panels
Premium

The CardioGenomic Testing Alliance aims to increase the utilization of NGS panels for numerous cardiac conditions including arrhythmias and cardiomyopathies.

Apr 4, 2022

International Heart Rhythm Societies Set Out Recommendations on Genetic Testing for Cardiac Diseases

Jan 21, 2022

Prolight Diagnostics to Acquire UK Point-of-Care Firm Psyros Diagnostics for $7.1M

Jan 18, 2022

NHS, Genomics PLC to Integrate Polygenic Risk Scores With Traditional Cardiovascular Risk Factors

Jun 30, 2021

Siemens Healthineers Rolling Out High-Sensitivity POC Troponin Assay in Europe
Premium

Mar 15, 2021

Quest Diagnostics, Zora Biosciences Sign Licensing Agreement for Cardiovascular Biomarkers

Dec 15, 2020

Proxim Diagnostics Developing Handheld Analyzer for Point-of-Care, SARS-CoV-2 Testing

Dec 9, 2020

Wyss Institute Developing Multiplex Electrochemical Testing Platform for Multiple Disease Conditions

Sep 9, 2020

AACC, CDC to Expand Lipid Testing Globally

Jul 24, 2020

MIP Diagnostics Developing SARS-CoV-2, Troponin Molecularly Imprinted Polymers

Mar 10, 2020

Prevencio, Microsoft Ink Agreement for AI-Based Cardiac Blood Tests

Jan 28, 2020

Spartan Bioscience Pushing to Commercialize Personalized Heart Test
Premium

Nov 21, 2019

Nightingale Health Launches Consumer Blood Testing Service, Announces Japanese Partners
Premium

Oct 2, 2019

Liquid Biopsy Test Targets Early Detection of Diabetes Complications, Cancers
Premium

Aug 19, 2019

Agilent Teams Up With Singapore University, Hospital for New $38M Hub for Clinical Diagnostics

Aug 14, 2019

Salveo Dx Merges With ImmunArray, Nudge

Aug 1, 2019

Ortho Clinical Diagnostics Receives Health Canada Approval for High Sensitivity Troponin I Assay

Jun 4, 2019

AMP, CAP Develop Guidelines for CYP2C9 PGX Assay Design
Premium

May 3, 2019

Including Troponin I in Cardiovascular Testing Leads to Earlier Detection of Heart Injury, Study Says
Premium

Apr 16, 2019

High-Sensitivity Troponin Assay From Ortho Clinical Diagnostics CE Marked

Apr 11, 2019

FH Foundation, Invitae, Genome Medical Partner on Genetic Testing Initiative